Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 03, 2022

SELL
$0.37 - $1.02 $185 - $510
-500 Closed
0 $0
Q4 2021

Feb 03, 2022

BUY
$0.98 - $1.86 $490 - $930
500 New
500 $0

Others Institutions Holding CYDY

About CytoDyn Inc.


  • Ticker CYDY
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 813,040,000
  • Market Cap $97.6M
  • Description
  • CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...
More about CYDY
Track This Portfolio

Track Steward Financial Group LLC Portfolio

Follow Steward Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Financial Group LLC with notifications on news.